Literature DB >> 22777593

Detection of phase I IgG antibodies to Coxiella burnetii with EIA as a screening test for blood donations.

W van der Hoek1, C C H Wielders, B Schimmer, M C A Wegdam-Blans, J Meekelenkamp, H L Zaaijer, P M Schneeberger.   

Abstract

The presence of a high phase I IgG antibody titre may indicate chronic infection and a risk for the transmission of Coxiella burnetii through blood transfusion. The outbreak of Q fever in the Netherlands allowed for the comparison of an enzyme immunoassay (EIA) with the reference immunofluorescence assay (IFA) in a large group of individuals one year after acute Q fever. EIA is 100 % sensitive in detecting high (≥1:1,024) phase I IgG antibody titres. The cost of screening with EIA and confirming all EIA-positive results with IFA is much lower than screening all donations with IFA. This should be taken into account in cost-effectiveness analyses of screening programmes.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22777593     DOI： 10.1007/s10096-012-1686-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  11 in total

1.  Sexually transmitted Q fever.

Authors:  A Milazzo; R Hall; P A Storm; R J Harris; W Winslow; B P Marmion
Journal:  Clin Infect Dis       Date:  2001-07-05       Impact factor: 9.079

Review 2.  The Q fever epidemic in The Netherlands: history, onset, response and reflection.

Authors:  H I J Roest; J J H C Tilburg; W van der Hoek; P Vellema; F G van Zijderveld; C H W Klaassen; D Raoult
Journal:  Epidemiol Infect       Date:  2010-10-05       Impact factor: 2.451

3.  Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in The Netherlands.

Authors:  Boris M Hogema; Ed Slot; Michel Molier; Peter M Schneeberger; Mirjam H Hermans; Erik J van Hannen; Wim van der Hoek; H Theo Cuijpers; Hans L Zaaijer
Journal:  Transfusion       Date:  2011-07-14       Impact factor: 3.157

4.  Q fever in the Netherlands: an update on the epidemiology and control measures.

Authors:  W van der Hoek; F Dijkstra; B Schimmer; P M Schneeberger; P Vellema; C Wijkmans; R ter Schegget; V Hackert; Y van Duynhoven
Journal:  Euro Surveill       Date:  2010-03-25

5.  Possible sexual transmission of Q fever among humans.

Authors:  D Kruszewska; K Lembowicz; S Tylewska-Wierzbanowska
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

6.  Q fever following bone marrow transplantation.

Authors:  E Kanfer; N Farrag; C Price; D MacDonald; J Coleman; A J Barrett
Journal:  Bone Marrow Transplant       Date:  1988-03       Impact factor: 5.483

Review 7.  Chronic Q fever: review of the literature and a proposal of new diagnostic criteria.

Authors:  M C A Wegdam-Blans; L M Kampschreur; C E Delsing; C P Bleeker-Rovers; T Sprong; M E E van Kasteren; D W Notermans; N H M Renders; H A Bijlmer; P J Lestrade; M P G Koopmans; M H Nabuurs-Franssen; J J Oosterheert
Journal:  J Infect       Date:  2011-12-23       Impact factor: 6.072

8.  Long-term persistence of Coxiella burnetii after acute primary Q fever.

Authors:  B P Marmion; P A Storm; J G Ayres; L Semendric; L Mathews; W Winslow; M Turra; R J Harris
Journal:  QJM       Date:  2005-01

9.  From acute Q fever to endocarditis: serological follow-up strategy.

Authors:  Cécile Landais; Florence Fenollar; Franck Thuny; Didier Raoult
Journal:  Clin Infect Dis       Date:  2007-04-04       Impact factor: 9.079

10.  Q fever serology: cutoff determination for microimmunofluorescence.

Authors:  H T Dupont; X Thirion; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-03
View more
  4 in total

1.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

Review 2.  Pneumococcal Vaccination Strategies. An Update and Perspective.

Authors:  Andrew C Berical; Drew Harris; Charles S Dela Cruz; Jennifer D Possick
Journal:  Ann Am Thorac Soc       Date:  2016-06

3.  Serology in chronic Q fever is still surrounded by question marks.

Authors:  M C A Wegdam-Blans; H T Tjhie; J M Korbeeck; M N Nabuurs-Franssen; L M Kampschreur; T Sprong; J A W Teijink; M P Koopmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-16       Impact factor: 3.267

4.  Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands.

Authors:  Pieter T de Boer; Marit M A de Lange; Cornelia C H Wielders; Frederika Dijkstra; Sonja E van Roeden; Chantal P Bleeker-Rovers; Jan Jelrik Oosterheert; Peter M Schneeberger; Wim van der Hoek
Journal:  Emerg Infect Dis       Date:  2020-02       Impact factor: 6.883
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.